Novonesis Forecast, price target & analysts
Novonesis Target price 2025 - Analyst rating & recommendation
Novonesis Classifications & Recommendation:
Novonesis Price Target
| Target Price | DKK503.51 |
| Price | DKK434.40 |
| Potential |
15.91%
register free of charge
|
| Number of Estimates | 17 |
|
17 Analysts have issued a price target Novonesis 2026 .
The average Novonesis target price is DKK503.51.
This is
15.91%
register free of charge
DKK597.98
37.66%
register free of charge
DKK387.96
10.69%
register free of charge
|
|
| A rating was issued by 18 analysts: 13 Analysts recommend Novonesis to buy, 3 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Novonesis stock has an average upside potential 2026 of
15.91%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion DKK | 28.59 | 31.72 |
| 59.75% | 10.92% | |
| EBITDA Margin | 30.77% | 37.39% |
| 5.96% | 21.52% |
16 Analysts have issued a sales forecast Novonesis 2025 . The average Novonesis sales estimate is
This results in the following potential growth metrics:
16 Analysts have issued an Novonesis EBITDA forecast 2025. The average Novonesis EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share DKK | 5.00 | 11.33 |
| 54.21% | 126.60% | |
| P/E | 37.68 | |
| EV/Sales | 6.61 |
10 Analysts have issued a Novonesis forecast for earnings per share. The average Novonesis <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Novonesis stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current Novonesis Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG | Locked ➜ Locked | Locked | Dec 08 2024 |
| BNP PARIBAS EXANE | Locked ➜ Locked | Locked | Nov 13 2024 |
| REDBURN ATLANTIC | Locked ➜ Locked | Locked | Nov 10 2024 |
| DNB MARKETS | Locked ➜ Locked | Locked | Nov 06 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BERENBERG: Locked ➜ Locked
|
Dec 08 2024 |
|
Locked
BNP PARIBAS EXANE: Locked ➜ Locked
|
Nov 13 2024 |
|
Locked
REDBURN ATLANTIC: Locked ➜ Locked
|
Nov 10 2024 |
|
Locked
DNB MARKETS: Locked ➜ Locked
|
Nov 06 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
